Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Cancer Treatment Reviews
|
July 1, 2011
Recent clinical developments and rationale for combining targeted agents in non-small cell lung cancer (NSCLC)
C P Belani, G Goss, G Blumenschein
International Journal of Cell Cloning
|
May 1, 1985
Clonogenic in vitro growth and histologic grading of primary human breast tumors
V Hug, R Rashid, G Blumenschein, et al.
Breast Cancer Research and Treatment
|
January 1, 1985
Regulation of breast tumor growth by high dose estrogen is independent of the presence of estrogen receptors
V Hug, B Drewinko, G N Hortobagyi, et al.
Clinical and Experimental Immunology
|
November 1, 1971
Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy
P Y Paterson, R Semo, G Blumenschein, et al.
Molecular Biotherapy
|
March 1, 1992
Combination biotherapy utilizing interleukin-2 and alpha interferon in patients with advanced cancer: a National Biotherapy Study Group Trial
R K Oldham, G Blumenschein, L Schwartzberg, et al.
American Journal of Clinical Oncology
|
February 1, 1983
A phase I-II study of continuous 5-day infusion mitomycin-C
H Y Yap, M Valdivieso, G Blumenschein, et al.
Cancer Treatment Reports
|
May 1, 1985
Effect of cyclophosphamide on the mitomycin-induced syndrome of thrombotic thrombocytopenic purpura
V Hug, A Burgess, G Blumenschein, et al.
Archives of Internal Medicine
|
February 1, 1983
Hormonal therapy for metastatic male breast cancer
H Kantarjian, H Y Yap, G Hortobagyi, et al.
Cancer Treatment Reports
|
August 1, 1982
Potential cardiotoxicity with mitoxantrone
F C Schell, H Y Yap, G Blumenschein, et al.
Cancer Treatment Reports
|
May 1, 1984
Phase I-II study of high-dose mitomycin with autologous bone marrow transplantation in refractory metastatic breast cancer
N Tannir, G Spitzer, K Dicke, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Cancer Treatment Reviews
|
July 1, 2011
Recent clinical developments and rationale for combining targeted agents in non-small cell lung cancer (NSCLC)
C P Belani, G Goss, G Blumenschein
International Journal of Cell Cloning
|
May 1, 1985
Clonogenic in vitro growth and histologic grading of primary human breast tumors
V Hug, R Rashid, G Blumenschein, et al.
Breast Cancer Research and Treatment
|
January 1, 1985
Regulation of breast tumor growth by high dose estrogen is independent of the presence of estrogen receptors
V Hug, B Drewinko, G N Hortobagyi, et al.
Clinical and Experimental Immunology
|
November 1, 1971
Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy
P Y Paterson, R Semo, G Blumenschein, et al.
Molecular Biotherapy
|
March 1, 1992
Combination biotherapy utilizing interleukin-2 and alpha interferon in patients with advanced cancer: a National Biotherapy Study Group Trial
R K Oldham, G Blumenschein, L Schwartzberg, et al.
American Journal of Clinical Oncology
|
February 1, 1983
A phase I-II study of continuous 5-day infusion mitomycin-C
H Y Yap, M Valdivieso, G Blumenschein, et al.
Cancer Treatment Reports
|
May 1, 1985
Effect of cyclophosphamide on the mitomycin-induced syndrome of thrombotic thrombocytopenic purpura
V Hug, A Burgess, G Blumenschein, et al.
Archives of Internal Medicine
|
February 1, 1983
Hormonal therapy for metastatic male breast cancer
H Kantarjian, H Y Yap, G Hortobagyi, et al.
Cancer Treatment Reports
|
August 1, 1982
Potential cardiotoxicity with mitoxantrone
F C Schell, H Y Yap, G Blumenschein, et al.
Cancer Treatment Reports
|
May 1, 1984
Phase I-II study of high-dose mitomycin with autologous bone marrow transplantation in refractory metastatic breast cancer
N Tannir, G Spitzer, K Dicke, et al.
Page
of 2